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Background: The effects of target temperature management (TTM) on the heart aren’t thoroughly studied yet.
Several studies showed the prolongation of various ECG parameters including Tpeak-Tend-time under TTM. Our
study’s goal is to evaluate the acute and long-term outcome of these prolongations.
Methods: In this study we included patients with successful resuscitation after cardiac arrest who were admitted to
the Charité Virchow Klinikum Berlin or the Heart and Vascular Centre of the Ruhr University Bochum between
February 2006 and July 2013 (Berlin) or May 2014 to November 2015 (Bochum). For analysis, one ECG during TTM
was recorded after reaching the target temperature (33–34 °C) or in the first 6 h of TTM. If possible, another ECG
was taken after TTM. The patients were being followed until February 2016.
Primary endpoint was ventricular arrhythmia during TTM, secondary endpoints were death and hospitalization due
to cardiovascular diseases during follow-up.
Results: One hundred fifty-eight patients were successfully resuscitated in the study period of which 95 patients
had usable data (e.g. ECGs without artifacts). During TTM significant changes for different parameters of ventricular
de- and repolarization were noted: QRS (103.2 ± 23.7 vs. 95.3 ± 18.1; p = 0.003),QT (405.8 ± 76.4 vs. 373.8 ± 75.0;
p = 0.01), QTc (474.9 ± 59.7 vs. 431.0 ± 56.8; p < 0.001), JT (302.8 ± 69.4 vs. 278.5 ± 75.2; p = 0.043), JTc (354.3 ± 60.2
vs. 318.7 ± 59.1; p = 0.001). 13.7% of the patients had ventricular arrhythmias during TTM, however these patients
showed no difference regarding their ECG parameters in comparison to those were no ventricular arrhythmias
occurred. We were able to follow 69 Patients over an average period of 35 ± 31 months. The 14 (21.5%) patients
who died during the follow-up had significant prolongations of the TpTe-time in the ECGs without TTM (103.
9 ± 47.2 vs. 75.8 ± 28.6; p = 0.023).
Conclusion: Our results show a significant prolongation of ventricular repolarization during TH. However, there was
no significant difference between the ECG parameters of those who developed a ventricular arrhythmia and those
who did not. The temporary prolongation of the repolarization during TTM seems to be less important for the
prognosis of the patient. Whereas the prolongation of the repolarization in the basal ECG is associated with a
higher mortality in our study.* Correspondence: sophie.freiin-von-ulmenstein@charite.de
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The European Resuscitation Council included target
temperature management (TTM) in its guidelines as a
method to prevent patients after cardiac arrest from
neurological damage [1, 2]. Nonetheless, its effect on the
heart is still not certain [3].
In the last years, several studies examined the effect of
TTM on different ECG parameters. The results suggest
that TTM causes the prolongation of various intervals
such as the QT interval and the Tpeak-to-Tend (TpTe)
interval but without an increase in life-threatening
arrhythmias [4, 5].
The TpTe interval reflects the transmural dispersion
of repolarization and is acknowledged to be a helpful
parameter to evaluate the risk of severe arrhythmic
events [6, 7]. However, its impact on patients under
TTM and its role as a prognostic marker for the acute
and long-term outcome of these patients is not
thoroughly studied.
The purpose of this study is to evaluate if it is possible
to establish TpTe and its relation to the QT interval as a




In this prospective cohort study patients with cardiac ar-
rest and successful resuscitation (survival over 24 h)
were included. Due to current guidelines and our local
standard protocol all survivors after cardiac arrest
received TTM if they remained comatose at time of
admission, despite location or type of cardiac arrest.
All the patients were admitted to the Charité Virchow
Klinikum Berlin or the Heart and Vascular Centre of the
Ruhr University Bochum between February 2006 and
July 2013 (Berlin) or May 2014 to November 2015
(Bochum) and underwent TTM at a target temperature
of 33 to 34 °C.
ECG analysis
We analyzed one ECG under hypothermia at 33.0 °C,
which was taken after reaching the target temperature
or in the first 6 h of TTM, and if available another ECG
without hypothermia at least 24 h after TTM. The man-
ual measurements of most of the intervals were obtained
from lead V1 or from the next readable chest lead. Only
the PQ interval was measured in lead II.
TpTe was defined as the interval of the highest or
lowest point of the T wave to the point where the T
wave intersects the isoelectric line. For biphasic T waves
the highest or lowest part of the first wave was taken
and measured until the end of the second wave. TpTe
was put into relation with the QT interval. The QT
interval was corrected with Bazett’s Formula.QRS fragmentation was characterized as QRS >120 ms
without a bundle branch block (BBB), notched R/S in
two consecutive leads, an RSR-configuration but QRS
<120 ms and no incomplete RBBB, >1 R’ in two
consecutive leads or QRS >120 ms and >2 R’.
The QT dispersion in this study was obtained from
the longest and the shortest QT interval in a 12-lead-
ECG.
Follow up
The Follow up of the patients was performed until
February 2016. New hospitalizations were registered and
their charts were reviewed. In addition, the German
population register was used to follow up for the death
of patients who were not admitted once more to the
Charité or the Ruhr University Bochum.
Data analysis
For all statistical analyses SPSS 21 (IBM, Armonk, NY,
USA) was utilized. To compare the ECG parameters
with and without hypothermia a paired t-test and
Wilcoxon’s test was conducted. Furthermore, a logistic
regression and a Kaplan-Meier survival-analysis were
performed.
Primary endpoint was ventricular arrhythmia during
TTM, secondary endpoints were death and




In our study, 158 patients were included between
February 2006 and November 2015. After reevaluation
of the ECGs 63 patients had to be excluded due to no
hypothermia, no readable ECG, no available chest leads
or indeterminable ECG date. Unfortunately, 39 patients
did not have an ECG without hypothermia in their
patient files and thus could only be used for the Baseline
characteristics and the long-term outcome.
The average age was 59.1 ± 16.2 and the patients were
mainly male (80%). In most cases the initial rhythm was
ventricular fibrillation (VF; 65.6%) and the cardiac arrest
was caused by an acute myocardial infarction (AMI;
52.6%). During hospitalization 26 patients died. The
mean ascertained APACHE II Score at admission was
27.6 ± 8.3. Typical concomitant diseases were coronary
artery disease (CAD; 67.4%), hypertension (46.3%), heart
failure (33.7%) and renal failure (25.3%). All baseline
characteristics are shown in Table 1.
A good outcome at discharge according to the
Cerebral Performance Category scale (CPC 1 or 2) was
seen in 58.9% of the patients.
A follow-up was performed until February 2016. Sixty
nine patients were followed during an average period of
Table 1 Baseline and follow-up characteristics
Baseline characteristics Patients (n = 95)
Age 59.1 (± 16.2)






Lay resuscitation 36 (37.5%)
Myocardial infarction 50 (52.6%)
Cardiomyopathy 6 (6.3%)
LVEF (%) 40.3 (± 13.8)
Died during hospitalization 26 (27.1%)
APACHE II 27.6 (± 8.3)
Time on ventilation (h) 309.8 (± 273.2)
Time on ICU (d) 19.1 (± 15.0)
CAD 64 (67.4%)
Previous myocardial infarction 9 (9.5%)
Previous ICD/Pacemaker 4 (4.2%)
Diastolic dysfunction 2 (2.1%)
Heart failure 32 (33.7%)
COPD 8 (8.4%)
Hypertension 44 (46.3%)
Renal failure 24 (25.3%)
Follow-up characteristics Patients
Death 27.8%
Newly diagnosed ventricular arrhythmia 5.6%
ICD shock 3.7%
Newly diagnosed SVT 7.4%
AMI 1.9%
VF ventricular fibrillation, VT ventricular tachycardia, PEA pulseless electrical
activity, LVEF left ventricular ejection fraction, ICU intensive care unit, CAD
coronary artery disease, COPD chronic obstructive pulmonary disease, SVT
supraventricular tachycardia, AMI acute myocardial infarction
Values are mean (SD) or numbers (%)
Table 2 Difference of ECG parameters during and after TTM
Measurements TTM After TTM n p-Value
PQ (ms) 159.0 (± 34.0) 147.3 (± 33.2) 40 .059
QRS (ms) 103.2 (± 23.7) 95.3 (± 18.1) 56 .002
QT (ms) 405.8 (± 76.4) 373.8 (± 75.0) 56 .010
QTc (ms) 474.9 (± 59.7) 431.0 (± 56.8) 56 .000
QTd (ms) 101.0 (± 46.2) 93.0 (± 46.8) 56 .234
JT (ms) 302.8 (± 69.4) 278.5 (± 75.2) 56 .043
JTc (ms) 354.3 (± 60.2) 318.7 (± 59.1) 56 .002
TpTe (ms) 92.4 (± 44.2) 80.5 (± 33.3) 54 .051
TpTe-QT-Ratio 0.23 (± 0.08) 0.21 (± 0.07) 54 .240
TpTe d 67.9 (± 39.9) 56.1 (± 35.1) 56 .099
Heart rate (−min) 86.3 (± 20.5) 85.2 (± 25.9) 56 .806
TTM targeted temperature management
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21 of the 54 remaining follow-up patients did not have
another hospitalization at the Charité and hence, we
could only collect the information if they died during
our observation period. Moreover, three patients had
ventricular arrhythmia, two patients had an ICD shock,
one patient had another AMI and 15 patients died
(Table 1).
ECG analysis
ECGs were taken during hypothermia and afterwards.
Several ECG parameters increased significantly dur-
ing hypothermia (Table 2): QRS (103.2 ± 23.7 vs.95.3 ± 18.1; p = 0.003), QT (405.8 ± 76.4 vs.
373.8 ± 75.0; p = 0.01), QTc (474.9 ± 59.7 vs.
431.0 ± 56.8; p = 0.000), JT (302.8 ± 69.4 vs.
278.5 ± 75.2; p = 0.043), JTc (354.3 ± 60.2 vs.
318.7 ± 59.1; p = 0.001). Although there was an in-
crease in the duration of these parameters, especially
QT/QTc, only 11.6% of the patients developed ven-
tricular tachycardia and 2.1% ventricular fibrillation
during hypothermia. Furthermore, the QT/QTc inter-
val and TpTe were not significantly longer in patients
who developed these arrhythmias (QT: p = 0.158;
QTc: p = 0.138; TpTe: p = 0.297; Table 3).
There was no significant difference in the heart rate
(86.3 ± 20.5 vs. 85.2 ± 25.9; p = 0.806). The PQ interval
could not be measured for several ECGs due to atrial
fibrillation, junctional rhythm or paced rhythm.
Long-term ECG results
Sixty nine patients were followed over a period of
35 months ±31 months. Fourteen patients died during
this period (21.5%). Patients who died during follow-up
showed a significant longer TpTe in the ECGs after
TTM (103.9 ± 47.2 vs. 75.8 ± 28.6; p = 0.023 Table 4) in
comparison to long-term survivors, while QT and QTc
values were not significantly different between the groups.
There was no significant difference in the 180-days-
survival between the groups of normal or prolonged
interval for the parameters QTc, TpTe and TpTe-QT-
ratio during TTM and after TTM.
Discussion
This study is to our knowledge the first one to analyze
the effect of TTM on different ECG parameters and
the long-term outcome in a large study population.
Hypothermia can lead to a prolongation of ventricular
repolarization, which subsequently can cause ventricu-
lar arrhythmias [6, 8].
Table 3 Ventricular arrhythmia during TTM
No ventricular arrhythmia Ventricular arrhythmia p-Value
PQ (ms) 163.5 (± 31.0) 171.3 (± 29.4) 0.437
QRS (ms) 102.9 (± 24.3) 96.9 (± 29.8) 0.610
QT (ms) 398.4 (± 75.0) 365.8 (± 86.8) 0.158
QTc (ms) 463.8 (± 61.4) 435.0 (± 81.9) 0.138
QTd (ms) 95.8 (± 44.9) 104.2 (± 44.4) 0.530
JT (ms) 295.4 (± 67.8) 268.9 (± 75.1) 0.200
JTc (ms) 343.9 (± 60.3) 319.2 (± 69.9) 0.183
TpTe (ms) 92.9 (± 38.8) 85.4 (± 28.5) 0.297
TpTe-QT-Ratio 0.23 (± 0.07) 0.24 (± 0.10) 0.643
TpTe d 67.7 (± 37.0) 68.5 (± 60.1) 0.380
Heart rate (−min) 85.5 (± 21.1) 89.3 (± 20.7) 0.547
TTM targeted temperature management, TpTe Tpeak-Tend-Time
Values are means (standard deviation)
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QT intervals during hypothermia are complex and are
partly due to serum electrolyte changes, which include
hypokalemia, increased intracellular Calcium and Sodium
concentration [9, 10]. The Calcium overload is most likely
the main factor behind severe cardiac arrhythmias [9, 10].
Moreover the myocardium doesn’t cool down homoge-
nously which leads to repolarization differences in the
tissue and thus can also cause arrhythmias [10].
Piktel et al. showed that TTM at 32 °C slightly in-
creased the TpTe in canines, but with a decreased
arrhythmogenesis and with TpTe going back to baseline
values after rewarming in comparison to canines which
underwent severe hypothermia at 26 °C [11].
As the study from Piktel et al. was conducted in
healthy canines without previous resuscitation, the re-
sults are most likely to vary from the effects of TTM in
resuscitated patients. Our results are consistent withTable 4 Death after discharge
No incidence Death p-Value
PQ (ms) 151.0 (± 32.9) 161.6 (± 60.5) 0.718
QRS (ms) 94.1 (± 19.3) 98.9 (± 17.6) 0.476
QT (ms) 374.0 (± 59.5) 410.0 (± 124.5) 0.420
QTc (ms) 422.9 (± 46.7) 464.9 (± 86.2) 0.191
QTd (ms) 91.9 (± 45.7) 90.0 (± 53.4) 0.697
JT (ms) 279.9 (± 60.3) 311.1 (± 124.9) 0.484
JTc (ms) 315.15 (± 48.7) 346.9 (± 92.4) 0.344
TpTe (ms) 75.8 (± 28.6) 103.9 (± 47.2) 0.023
TpTe-QT-Ratio 0.20 (± 0.07) 0.25 (± 0.05) 0.076
TpTe d 59.0 (± 37.9) 48.9 (± 17.6) 0.667
Heart rate(−min) 80.33 (± 21.0) 88.2 (± 38.6) 0.567
TTM targeted temperature management, TpTe Tpeak-Tend-time
ECG after TTM. Values are means (standard deviation)previous studies regarding the acute effect of TH in
showing a prolongation of QT/QTc – with no significant
prolongation of QTd and TpTe - and without an in-
crease of severe arrhythmic events [4, 5]. Moreover,
there was no significant difference regarding the ECG
parameters in patients with ventricular arrhythmia dur-
ing TTM and patients without ventricular arrhythmias.
Hence, the temporary prolongation of the ECG parame-
ters doesn’t seem to be of prognostic importance.
Although the TpTe interval was not significantly pro-
longed during TTM, patients who died after their
hospitalization had a significant longer TpTe interval in
general. This is consistent with previous studies that
evaluated the TpTe as a marker of sudden cardiac death
in the general population [12].
Limitations
No ECGs were available in advance to the hypothermia.
However, another study showed that the QT time is de-
creasing after hypothermia to baseline levels [4]. Hence,
it can be assumed that the QT time after hypothermia is
the same as before. Moreover our study was conducted
in patients with a target temperature at 33–34 °C. The
new guidelines however allow a temperature between 32
and 36 °C, thus the effects on the heart could vary from
our results in a different temperature management [13].
Additionally, the study was performed without a
control group of patients, who didn’t receive TTM after
cardiac arrest. Therefore, the ECG changes during TTM
could also be caused by other factors, e.g. ventricular
adaptation after cardiac arrest. It might be useful to
conduct a similar study with a control group to exclude
such a phenomenon. However, since TTM is standard
treatment in postresuscitation care, it is difficult to de-
fine a control group. The best match would be a group
of patients after cardiac arrest that was not treated with
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was not possible at our hospitals and therefore, a control
group could not be added.Conclusion
Our study showed a significant prolongation of the ven-
tricular repolarization under TTM. However, this pro-
longation doesn’t correlate with the incidence of
ventricular arrhythmias. Therefore, it’s not advisable to
use it as a prognostic marker.
Nonetheless, it might be worth thinking about establish-
ing TpTe as a risk marker in ECGs without TTM. Further
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